Janus Henderson Group PLC Madrigal Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,191,753 shares of MDGL stock, worth $787 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
2,191,753
Previous 2,205,849
0.64%
Holding current value
$787 Million
Previous $731 Million
9.22%
% of portfolio
0.34%
Previous 0.42%
Shares
15 transactions
Others Institutions Holding MDGL
# of Institutions
354Shares Held
23.3MCall Options Held
745KPut Options Held
476K-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$750 Million32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$716 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$709 Million6.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$674 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.88MShares$673 Million10.35% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...